We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| OSE Immunotherapeutics | EU:OSE | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.26 | -2.42% | 10.48 | 10.48 | 10.52 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 11.18 | 10.48 | 10.78 | 192,327 | 11:02:58 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 04/11/2024 | 17:00 | UKREG | Informations relatives au nombre total de droits de vote et d’actions.. |
| 04/11/2024 | 06:30 | UKREG | OSE Immunotherapeutics Announces Statistically Significant and Clinically.. |
| 04/11/2024 | 06:30 | UKREG | OSE Immunotherapeutics Annonce des Résultats Cliniquement Probants et.. |
| 17/10/2024 | 16:00 | UKREG | OSE Immunotherapeutics présente une nouvelle technologie bispécifique de.. |
| 17/10/2024 | 16:00 | UKREG | OSE Immunotherapeutics Presents New “Cis-Demasking” Bispecific Technology.. |
| 02/10/2024 | 16:00 | UKREG | Informations relatives au nombre total de droits de vote et d’actions.. |
| 26/9/2024 | 16:00 | UKREG | OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides.. |
| 26/9/2024 | 16:00 | UKREG | OSE Immunotherapeutics annonce des résultats semestriels 2024 remarquables.. |
| 10/9/2024 | 05:30 | UKREG | OSE Immunotherapeutics annonce le lancement international d’Artemia,.. |
| 10/9/2024 | 05:30 | UKREG | OSE Immunotherapeutics Announces Global Launch of Artemia Phase 3.. |
1 Year OSE Immunotherapeutics Chart |
Intraday OSE Immunotherapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
